TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their outlooks on several US-listed companies, including nCino, Intuit, Medtronic, Draganfly, Starbucks, Ibotta, TJX Companies, TeraWulf, Nurix Therapeutics, and Sportradar Group. These updates include both upgrades and downgrades, with changes in price targets and ratings.
August 14, 2024 | 11:43 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HC Wainwright & Co cut the price target for Draganfly from $1 to $0.5 but maintained a Buy rating.
Despite maintaining a Buy rating, the significant reduction in the price target may lead to a short-term decline in Draganfly's stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Morgan Stanley downgraded Intuit from Overweight to Equal-Weight and reduced the price target from $750 to $685.
The downgrade and reduced price target from Morgan Stanley may lead to a short-term decline in Intuit's stock price as investors adjust their expectations.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Stifel downgraded Medtronic from Buy to Hold and cut the price target from $100 to $85.
The downgrade and reduced price target from Stifel may result in a short-term decline in Medtronic's stock price as investor sentiment turns cautious.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Needham lowered Ibotta's price target from $125 to $100 but maintained a Buy rating.
The maintained Buy rating suggests continued confidence, but the reduced price target may temper short-term price gains.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Goldman Sachs raised the price target for nCino from $34 to $42 and upgraded the stock from Neutral to Buy.
The upgrade and increased price target from a reputable firm like Goldman Sachs is likely to boost investor confidence and drive short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Oppenheimer boosted Nurix Therapeutics' price target from $25 to $27 and maintained an Outperform rating.
The increased price target and maintained Outperform rating from Oppenheimer is likely to boost investor confidence and drive short-term price appreciation for Nurix Therapeutics.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Evercore ISI Group upgraded Starbucks from In-Line to Outperform and raised the price target from $80 to $120.
The upgrade and increased price target from Evercore ISI Group is likely to boost investor confidence and drive short-term price appreciation for Starbucks.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jefferies upgraded Sportradar Group from Hold to Buy and raised the price target from $12 to $16.
The upgrade and increased price target from Jefferies is likely to boost investor confidence and drive short-term price appreciation for Sportradar Group.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Telsey Advisory Group increased the price target for TJX Companies from $115 to $128 and maintained an Outperform rating.
The increased price target and maintained Outperform rating from Telsey Advisory Group is likely to boost investor confidence and drive short-term price appreciation for TJX.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Rosenblatt raised TeraWulf's price target from $4.2 to $5 and maintained a Buy rating.
The increased price target and maintained Buy rating from Rosenblatt is likely to boost investor confidence and drive short-term price appreciation for TeraWulf.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70